DEC 01, 2017 10:05 AM PST

Attacking Persistent Bacteria

As many of us are aware, the antimicrobial resistance crisis is now regarded as a global public health threat. Bacterial cells involved in persistent infections are of particular concern. These cells are in a quasidormant state, where they are metabolically inactive, allowing the bacteria to avoid the activity of antibiotic drugs.

A new report published in Antimicrobial Agents and Chemotherapy demonstrated that the administration of fumarate increased the efficacy of antibiotics toward killing persistent Pseudomonas aeruginosa cells. Credit: James Archer, CDC.

Chronic or persistent bacterial infections often require a longer treatment course with antibiotics, such as those infections caused by Mycobacterium tuberculosis and Pseudomonas aeruginosa. These persistent species of bacteria have the ability to remain in a state of dormancy or “metabolic hibernation” for weeks or even months in chronically ill patients only to later reemerge in a more aggressive state that can worsen the infection.

Researchers recently sought to determine how they could increase the efficacy of antibiotic treatment of Pseudomonas aeruginosa, which can cause persistent infections in cystic fibrosis (CF) patients. Pseudomonas aeruginosa is able to grow in the mucous that accumulates in the lungs of CF patients and produce biofilms, which are harder to treat using antibiotics.

Interestingly, the research team found that they could completely eradicate persistent Pseudomonas aeruginosa cells when the antibiotic tobramycin was administered with the metabolite fumarate. Out of the 21 clinical isolates tested, only 2 of them did not demonstrate better killing when fumarate was added along with tobramycin.

Fumarate plays a part in the glycolytic pathway where it generates ATP inside bacterial cells, allowing tobramycin uptake through active transport. This finding benefits CF patients specifically, because tobramycin is already approved for use to control chronic Pseudomonas aeruginosa infection in CF patients.

The authors of this study reported that no pathological effects were observed in cell culture upon treatment with tobramycin and fumarate. Although more experiments need to be performed, authors are confident that these results are a promising step toward increasing the efficacy of antibiotics toward persistent bacterial infections.

Sources: mBiosphere, Antimicrobial Agents and Chemotherapy

About the Author
  • I am a postdoctoral researcher with interests in pre-harvest microbial food safety, nonthermal food processing technologies, zoonotic pathogens, and plant-microbe interactions. My current research projects involve the optimization of novel food processing technologies to reduce the number of foodborne pathogens on fresh produce. I am a food geek!
You May Also Like
OCT 21, 2019
Earth & The Environment
OCT 21, 2019
What role does a light-capturing marine microbe play in climate regulation?
A USC-led research team discovered the unique role that a light-capturing marine microbe plays in regulating Earth’s climate. The team consisted of s...
OCT 21, 2019
Microbiology
OCT 21, 2019
Colombia Declares a State of Emergency as Banana Fungus Reaches the Americas
Bananas: the world's most popular fruit, a major source of food for millions of people, and now, seriously threatened by fungus....
OCT 21, 2019
Microbiology
OCT 21, 2019
A Microbe That Makes Methane From Oil is Found in the Gulf of Mexico
Archaea occupy their own branch on the tree of life and exist in some of the most extreme environments on the planet....
OCT 21, 2019
Microbiology
OCT 21, 2019
To Maintain Diversity in the Microbiome, Wild Animals Need Their Natural Foods
Bacterial communities can be vital partners to many living organisms, from humans beings to the white-throated woodrat....
OCT 21, 2019
Microbiology
OCT 21, 2019
Bacterial Enzyme Strips Inflammatory Carbohydrate From Meat
Humans don't make a carbohydrate called Neu5Gc, but most mammals, including cows, do....
OCT 21, 2019
Microbiology
OCT 21, 2019
Learning More About Toxoplasmosis
Around a third of the global population, including 40 million Americans are thought to be infected with a parasite called Toxoplasma gondii...
Loading Comments...